KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2KâMAPK1 inhibition
Janardhan, Harish Palleti, Meng, Xiuling, Dresser, Karen, Hutchinson, Lloyd, Trivedi, Chinmay M.Volume:
217
Journal:
Journal of Experimental Medicine
DOI:
10.1084/jem.20192205
Date:
July, 2020
Fichier:
PDF, 7.74 MB
2020